<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Genomic aberrations of Fms-like tyrosine kinase 3 (FLT3), including internal tandem duplication (ITD) and point mutations, have been demonstrated in 25-30% of adults <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) and are markers of poor prognosis </plain></SENT>
<SENT sid="1" pm="."><plain>FLT3/ITD and D835 mutations were analyzed in 194 Chinese patients with <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> and <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) by polymerase chain reaction (PCR) </plain></SENT>
<SENT sid="2" pm="."><plain>FLT3/ITDs and D835 mutations were found in 25.9 and 6.3% of 143 AML patients, respectively </plain></SENT>
<SENT sid="3" pm="."><plain>Two patients showed both ITD and point mutations </plain></SENT>
<SENT sid="4" pm="."><plain>Among the FAB subtypes of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>, the rate of FLT3 aberration was significantly higher in M3 and M5 </plain></SENT>
<SENT sid="5" pm="."><plain>However, neither aberrations was found in 25 patients with <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo> (ALL), 2 <z:hpo ids='HP_0011009'>acute</z:hpo> hybrid <z:hpo ids='HP_0001909'>leukemia</z:hpo>, 17 MDS and 7 <z:hpo ids='HP_0011010'>chronic</z:hpo> myeloid <z:hpo ids='HP_0001909'>leukemia</z:hpo> in <z:e sem="disease" ids="C0005699" disease_type="Neoplastic Process" abbrv="">blast crisis</z:e> (<z:mp ids='MP_0005481'>CML</z:mp>-BC) </plain></SENT>
<SENT sid="6" pm="."><plain>FLT3/ITD was associated to <z:hpo ids='HP_0001974'>leukocytosis</z:hpo> and lower complete remission (CR) rate, and was more prevalent in patients with <z:mpath ids='MPATH_458'>normal</z:mpath> karyotype </plain></SENT>
<SENT sid="7" pm="."><plain>In contrast, D835 mutation was not associated with <z:hpo ids='HP_0001974'>leukocytosis</z:hpo> or low CR rate </plain></SENT>
<SENT sid="8" pm="."><plain>Our results confirm that FLT3 activating mutations also occur in a significant percentage in Chinese <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> patients </plain></SENT>
<SENT sid="9" pm="."><plain>FLT3/ITD(+) patients treated with standard induction regimen could achieve lower complete remission rates compared with patients not harboring this defect </plain></SENT>
<SENT sid="10" pm="."><plain>Early detection of FLT3 mutations and an intensification of induction therapy might thus be useful for this group of patients to overcome the poor prognosis </plain></SENT>
</text></document>